Skip to main content
Clinical Trials/NCT04006535
NCT04006535
Recruiting
Not Applicable

Identification of Susceptibility Loci and Genes for Systemic Vasculitis Risk, by Analyzing Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis (FAMILYVASC Study)

Benjamin Terrier1 site in 1 country100 target enrollmentJune 1, 2019
ConditionsVasculitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vasculitis
Sponsor
Benjamin Terrier
Enrollment
100
Locations
1
Primary Endpoint
Identification of susceptibility loci and genes
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

The FAMILYVASC study is a prospective observational study which will aim to identify susceptibility loci and genes for systemic vasculitis risk in patients with familial or pediatric forms of vasculitis. Genetic analysis based on whole exome sequencing will be carried out through salivary DNA.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
June 1, 2029
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Benjamin Terrier

Professor

French Vasculitis Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Identification of susceptibility loci and genes

Time Frame: At the moment of enrollment

Study Sites (1)

Loading locations...

Similar Trials